000 | 01230 a2200313 4500 | ||
---|---|---|---|
005 | 20250516185235.0 | ||
264 | 0 | _c20141009 | |
008 | 201410s 0 0 eng d | ||
022 | _a1759-4804 | ||
024 | 7 |
_a10.1038/nrrheum.2013.203 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIsenberg, David A | |
245 | 0 | 0 |
_aSystemic lupus erythematosus in 2013. Taking a closer look at biologic therapy for SLE. _h[electronic resource] |
260 |
_bNature reviews. Rheumatology _cFeb 2014 |
||
300 |
_a71-2 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xtherapeutic use |
650 | 0 | 4 | _aBiological Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
650 | 0 | 4 |
_aMycophenolic Acid _xanalogs & derivatives |
650 | 0 | 4 | _aRituximab |
650 | 0 | 4 | _aTranslational Research, Biomedical |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aRahman, Anisur | |
773 | 0 |
_tNature reviews. Rheumatology _gvol. 10 _gno. 2 _gp. 71-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nrrheum.2013.203 _zAvailable from publisher's website |
999 |
_c23371889 _d23371889 |